SiriusPoint (SPNT) AI Stock Analysis

• Market Cap: $2.44B
• Dividend Yield: N/A
• Average Volume (3M): 548.38K
• Price to Earnings (P/E): 13.2
• Beta (1Y): 0.30
• Revenue Growth: 7.87%
• EPS Growth: -4.68%
• Country: US
• Employees: 1,012
• Sector: Financial
• Sector Strength: 70
• Industry: Insurance - Reinsurance
• EPS (TTM): 0.72
• Shares Outstanding: 116,814,640
• 10 Day Avg. Volume: 547,348
• 30 Day Avg. Volume: 548,376
• PEG Ratio: -0.30
• Price to Book (P/B): 1.41
• Price to Sales (P/S): 1.05
• P/FCF Ratio: 36.54
• Enterprise Value/Market Cap: 1.25
• Enterprise Value/Revenue: 1.08
• Enterprise Value/Gross Profit: 3.93
• Enterprise Value/Ebitda: 9.01
• 1Y Price Target: $27.50
• Price Target Upside: 31.39% Upside
• Rating Consensus: Moderate Buy
• Number of Analyst Covering: 2
• EPS Forecast (FY): 2.33
• Revenue Forecast (FY): $2.62B

• Rating: 75 Outperform
• Price Target: $23.00 ▲(9.89% Upside)

SiriusPoint's strong earnings call performance and robust financials are the primary drivers of its stock score. While technical indicators suggest overbought conditions, the company's strategic achievements and valuation provide a balanced outlook.

Positive Factors

Revenue Growth

Consistent double-digit growth in premiums indicates strong market demand and effective sales strategies, supporting long-term revenue expansion.

Operating Return on Equity

Exceeding ROE targets reflects efficient capital utilization and strong profitability, enhancing shareholder value over the long term.

Cash Flow Generation

Robust cash flow growth ensures financial flexibility, enabling strategic investments and debt reduction, supporting sustainable business operations.

Negative Factors

Higher Catastrophe Losses

Increased catastrophe losses can strain financial resources and impact profitability, posing a risk to long-term financial stability.

Decrease in Favorable Prior Year Development

Reduced favorable prior year development may indicate challenges in reserve management, potentially affecting future earnings predictability.

Decreased Aviation Premium

Declining aviation premiums highlight competitive pressures and pricing challenges, which may hinder revenue growth in this segment.

SiriusPoint Business Overview & Revenue Model

Company Description

SiriusPoint Ltd. is a global provider of insurance and reinsurance solutions, operating primarily in the specialty and reinsurance sectors. The company offers a range of products including property, casualty, and accident and health insurance, as well as reinsurance services across various lines of business. SiriusPoint leverages advanced analytics and technology to enhance its underwriting capabilities and risk management, positioning itself to serve clients ranging from corporations to governments and other insurance companies worldwide.

How the Company Makes Money

SiriusPoint generates revenue primarily through the underwriting of insurance and reinsurance policies. The company's revenue model includes premiums collected from policyholders in exchange for coverage, which is a significant revenue stream. Additionally, it earns income from reinsurance agreements where it takes on risk from other insurers for a fee. Investment income from the management of its insurance reserves also contributes to revenues, as the company invests premium funds in various financial instruments. Strategic partnerships with brokers and other insurance firms enhance its distribution capabilities, while its focus on innovative risk solutions allows it to capture niche market opportunities, further boosting its earnings.

SiriusPoint Financial Statement Overview

Summary

SiriusPoint exhibits strong financial performance with solid revenue growth and improved profitability. The balance sheet is stable with low leverage, and cash flow generation is robust. However, there is room for operational efficiency improvements and careful debt management.

Income Statement

SiriusPoint has shown a solid revenue growth rate of 7.3% in the TTM, indicating a positive trajectory. The gross profit margin is healthy at 37.5%, and the net profit margin has improved to 8.4%, reflecting enhanced profitability. However, the EBIT and EBITDA margins are relatively modest at 6.9% and 7.2%, respectively, suggesting room for operational efficiency improvements.

Balance Sheet

The company's debt-to-equity ratio is low at 0.32, indicating a conservative leverage approach. Return on equity stands at 11.5%, showcasing effective use of equity to generate profits. The equity ratio is strong, reflecting a stable financial position. However, the total debt has increased slightly, which could pose a risk if not managed carefully.

Cash Flow

SiriusPoint's cash flow performance is robust, with a significant free cash flow growth rate of 71.8% in the TTM. The operating cash flow to net income ratio is strong, indicating efficient cash generation relative to net income. The free cash flow to net income ratio is 1.0, demonstrating that the company is effectively converting its net income into free cash flow.

Breakdown	TTM	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	2.84B	2.61B	2.70B	2.17B	2.22B	884.50M
Gross Profit	778.70M	728.40M	848.40M	121.30M	510.40M	232.10M
EBITDA	339.80M	314.60M	393.90M	-376.00M	85.00M	160.10M
Net Income	198.30M	199.90M	354.80M	-386.80M	58.10M	143.80M
Balance Sheet
Total Assets	12.46B	12.52B	12.87B	11.04B	10.62B	3.54B
Cash, Cash Equivalents and Short-Term Investments	3.12B	3.57B	6.10B	4.33B	2.08B	526.00M
Total Debt	682.50M	639.10M	786.20M	778.00M	816.70M	114.30M
Total Liabilities	10.25B	10.59B	10.34B	8.95B	8.12B	1.97B
Stockholders Equity	2.21B	1.94B	2.51B	2.07B	2.50B	1.56B
Cash Flow
Free Cash Flow	232.10M	74.70M	581.30M	292.50M	1.60M	73.36M
Operating Cash Flow	232.10M	74.70M	581.30M	293.30M	1.60M	73.36M
Investing Cash Flow	437.70M	343.60M	-332.20M	-1.30B	208.60M	6.11M
Financing Cash Flow	-743.70M	-625.00M	-61.50M	-23.70M	24.30M	-19.48M

SiriusPoint Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 20.93
• 50DMA: Positive
• 100DMA: Positive
• 200DMA: Positive
• MACD: Negative
• RSI: Negative
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For SPNT, the sentiment is Positive. The current price of 20.93 is above the 20-day moving average (MA) of 19.79, above the 50-day MA of 18.79, and above the 200-day MA of 18.07, indicating a bullish trend. The MACD of 0.54 indicates Negative momentum. The RSI at 70.44 is Negative, neither overbought nor oversold. The STOCH value of 75.01 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for SPNT.

SiriusPoint Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
HG	81 Outperform	$2.71B	6.29	17.62%	―	22.79%	-5.17%
RNR	78 Outperform	$12.03B	7.25	14.98%	0.60%	-3.96%	-48.08%
RGA	76 Outperform	$12.54B	14.74	7.19%	1.91%	2.10%	19.23%
SPNT	75 Outperform	$2.44B	13.24	8.09%	―	7.87%	-4.68%
Sector *	68 Neutral	$18.00B	11.42	9.92%	3.81%	9.73%	1.22%
GLRE	61 Neutral	$448.58M	―	-0.28%	―	5.83%	-101.38%
OXBR	45 Neutral	$11.22M	-3.38	-50.32%	―	―	55.30%

SiriusPoint Corporate Events

SiriusPoint Ltd’s Earnings Call Highlights Robust Growth

SiriusPoint Ltd’s recent earnings call painted a picture of robust financial health, underscored by significant growth in premiums, operating return on equity, and investment income. The company celebrated notable achievements such as successful MGA disposals and multiple outlook upgrades. However, challenges remain, including higher year-to-date catastrophe losses and decreased favorable prior year development.

SiriusPoint Completes Sale of ArmadaCare to Ambac

On October 31, 2025, SiriusPoint Ltd. completed the sale of its wholly owned supplemental health insurance program manager, ArmadaCare, to Ambac Financial Group Inc. for $250 million. This transaction, initially announced on September 29, 2025, marks a strategic move for SiriusPoint, potentially impacting its market positioning and operational focus.

The most recent analyst rating on (SPNT) stock is a Buy with a $25.00 price target. To see the full list of analyst forecasts on SiriusPoint stock, see the SPNT Stock Forecast page.

SiriusPoint Reports Strong Q3 2025 Performance

On October 30, 2025, SiriusPoint Ltd. announced its third quarter results for 2025, highlighting a strong performance with a core combined ratio of 89.1% and an 11% increase in underwriting income. The company reported a return on equity of 17.7% and a significant growth in gross premiums written, marking the sixth consecutive quarter of double-digit growth. The announcement also included a quarterly cash dividend approval and the expected value increase from the sale of two MGA investments. Despite challenges from California wildfires and the aviation sector, SiriusPoint’s strategic growth and operational improvements have positioned it well within its target range, with a positive outlook upgrade from S&P.

The most recent analyst rating on (SPNT) stock is a Hold with a $19.50 price target. To see the full list of analyst forecasts on SiriusPoint stock, see the SPNT Stock Forecast page.

SiriusPoint Announces Chief Accounting Officer Resignation

On October 13, 2025, SiriusPoint Ltd. announced the resignation of Evan Cabat, the Chief Accounting Officer, effective October 31, 2025, as he pursues another opportunity. The company clarified that his departure is not due to any disagreements regarding financial or operational matters. Jim McKinney, the Chief Financial Officer, will take over Cabat’s responsibilities, ensuring continuity in the company’s financial leadership.

The most recent analyst rating on (SPNT) stock is a Hold with a $20.00 price target. To see the full list of analyst forecasts on SiriusPoint stock, see the SPNT Stock Forecast page.

SiriusPoint Sells Stake in Arcadian Risk Capital

On October 3, 2025, SiriusPoint Ltd. announced the sale of its 49% equity stake in Arcadian Risk Capital to Lee Equity Partners for $139 million, with the transaction expected to close by the first quarter of 2026. The deal includes an extension of SiriusPoint’s capacity agreement with Arcadian until 2031, and upon completion, SiriusPoint will recognize a pre-tax gain of $25-30 million. This move is part of SiriusPoint’s strategy to strengthen its partnership with Arcadian and support its growth under the leadership of John Boylan.

The most recent analyst rating on (SPNT) stock is a Hold with a $20.00 price target. To see the full list of analyst forecasts on SiriusPoint stock, see the SPNT Stock Forecast page.

SiriusPoint Announces Sale of ArmadaCare to Ambac

On September 29, 2025, SiriusPoint Ltd. announced an agreement to sell its wholly owned supplemental health insurance program manager, ArmadaCare, to Ambac Financial Group Inc. for $250 million. The transaction, expected to close in the fourth quarter of 2025, will result in a pre-tax gain of $220-230 million for SiriusPoint and an increase in its pro-forma tangible book value by approximately 10%. The sale is part of SiriusPoint’s strategy to unlock off-balance sheet value while continuing its capacity partnership with ArmadaCare until 2030, reflecting its strong position in the Accident & Health segment.

The most recent analyst rating on (SPNT) stock is a Hold with a $20.00 price target. To see the full list of analyst forecasts on SiriusPoint stock, see the SPNT Stock Forecast page.

SiriusPoint Appoints Martin Hudson to Board

On September 3, 2025, SiriusPoint Ltd. announced the appointment of Martin Hudson to its board of directors, effective September 1, 2025. With over 40 years of experience in the (re)insurance industry, Hudson’s leadership spans underwriting, risk management, and executive management across global markets. His appointment is expected to strengthen SiriusPoint’s business and support its growth strategies, delivering long-term value for shareholders and stakeholders.

The most recent analyst rating on (SPNT) stock is a Hold with a $20.00 price target. To see the full list of analyst forecasts on SiriusPoint stock, see the SPNT Stock Forecast page.